Disease | pulmonary hypertension |
Phenotype | C0040188|tic disorders |
Sentences | 3 |
PubMedID- 21490767 | The accumulation of excessive echb in plasma intensifies the consumption of endogenous nitric oxide (no), resulting in several cellular dysfunctions such as vasoconstriction and systemic and pulmonary hypertension in patients with hemolytic disorders including sca. |
PubMedID- 25077000 | Because of a unique pathophysiology, pulmonary hypertension associated with hemolytic disorders was moved from who group i to group v ph diseases. |
PubMedID- 20522578 | The pathogenesis of pulmonary hypertension in hemolytic disorders is likely multifactorial, including hemolysis, impaired nitric oxide (no) bioavailability, chronic hypoxemia, chronic thromboembolic disease, chronic liver disease, and asplenia. |
Page: 1